RIVER 3 RENAL
River 3 Renal is a developer of novel therapies designed to target orphan diseases in the renal space. The company's technology has the potential to address the unmet need in several kidney diseases, by further improving the standard of care, enabling medical practitioners to treat patients in a better way. River 3 Renal was established in 2020 in New York, USA.
RIVER 3 RENAL
Industry:
Health Care Health Diagnostics Medical
Founded:
2020-01-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
Total Funding:
40 M USD
Investors List
SR One
SR One investment in Series A - River 3 Renal
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Series A - River 3 Renal